Skip to content
Clinical Trials – home

MUDr. Petr Buček s.r.o.

Verified siteinfo

Czechia Vitezslava Nezvala 604, Mistek, 738 01 Frydek-Mistek, Czechia

  • 1 trial recruiting
  • Chronic kidney disease · Hypertension
  • Adult patients

About Specializations

MUDr. Petr Buček s.r.o. in Frydek-Mistek, Czechia specialises in clinical trials of conditions such as Chronic kidney disease, Hypertension, and other specialisations. This site conducts important research.

Main research areas of the site

Nephrology and Hypertension

The medical center is at the forefront of research in nephrology and hypertension, focusing on innovative treatments for chronic kidney disease (CKD) and high blood pressure. The center's work aims to improve patient outcomes through advanced therapeutic strategies.

  • Chronic Kidney Disease Management
  • Hypertension Control
  • Renal Function Preservation

By integrating cutting-edge research with clinical practice, the center contributes significantly to the understanding and management of kidney-related disorders, enhancing the quality of life for patients worldwide.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Vitezslava Nezvala 604, Mistek738 01 Frydek-MistekCzechia
Recruiting now
1 trial
Conditions studied
2
Partner status
Verified site

More sites in Frydek-MistekCzechia

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

3 clinical trials

Study on the Effects of Baxdrostat and Dapagliflozin in Adults with Chronic Kidney Disease and High Blood Pressure

Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB

Chronic kidney disease+1

Not recruiting

Study on Baxdrostat and Dapagliflozin for Adults with Chronic Kidney Disease and High Blood Pressure

Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB

Study on the Effectiveness and Safety of Finerenone for Adults with Non-Diabetic Chronic Kidney Disease

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Finerenone
  • Sponsor:Bayer AG
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.